StockSignal
How to use the screener to identify companies where substantial innovation investment shapes the balance sheet and defines where value resides.
The Question
How do I find companies that invest heavily in R&D and innovation? In knowledge-based industries, research and development spending is the primary mechanism for creating future competitive advantages. But R&D does not appear on the balance sheet — it is expensed immediately under most accounting standards, which means it reduces current earnings while creating future value that financial statements do not capture. This accounting treatment makes heavy R&D spenders look less profitable than peers who invest less, even when the investment is building a more durable competitive position.
This article examines two related structural dimensions: R&D investment intensity (how much a company spends on research relative to its business) and intangible asset concentration (how much of the balance sheet consists of non-physical assets like intellectual property, patents, brands, and acquisition goodwill). These dimensions often overlap — R&D-intensive companies tend to generate intangible assets — but they capture different aspects of how innovation investment appears in the financials. R&D spending is the current investment. Intangible assets are the accumulated result of past investments and acquisitions.
What Innovation Investment Means Structurally
Innovation investment is a structural commitment to future capability at the expense of current profitability. When a pharmaceutical company spends $4 billion annually on R&D, that spending flows through the income statement as an expense, reducing earnings and margins. But the pipeline of drug candidates it produces is an asset — one that accounting rules do not allow on the balance sheet until the products reach certain development milestones or are acquired from another company. This creates a systematic distortion in how R&D-intensive companies appear in standard financial screens: they look less profitable and less asset-rich than they actually are, because their most valuable investments are invisible to the balance sheet.
Intangible asset concentration tells a complementary story. When a company's balance sheet is dominated by intangible assets — patents, trademarks, software, customer relationships, and especially goodwill from acquisitions — the company's economic value resides in non-physical property. This is not inherently good or bad, but it is structurally distinct from companies whose value resides in factories, equipment, and inventory. Intangible-heavy companies have different risk profiles (intangible assets can lose value suddenly through technological disruption or competitive entry), different capital requirements (they often need less physical capital to grow), and different accounting characteristics (amortization schedules for intangibles may not reflect actual economic depreciation).
The screener's innovation stories capture these structural characteristics by measuring R&D spending intensity, tracking changes in investment levels over time, and decomposing the balance sheet into its tangible and intangible components. The combination reveals not just whether a company invests in innovation, but how central innovation investment is to the company's economic structure and where the accumulated results of that investment reside on the balance sheet.
Key Signals
R&D to Revenue
What it measures: Research and development spending as a percentage of total revenue — the most direct measure of innovation investment intensity. A company spending 20% of revenue on R&D is making a fundamentally different structural commitment than one spending 2%. This signal captures the magnitude of the company's ongoing innovation investment relative to the business it currently generates. High R&D-to-revenue ratios are characteristic of technology, pharmaceutical, biotechnology, and semiconductor companies where product cycles are short and competitive advantage depends on continuous development. The signal does not assess R&D productivity — whether the spending produces valuable output — only its structural intensity relative to the top line.
Data source: Research and development expense from the income statement divided by total revenue, tracked over multiple periods to establish spending patterns and identify changes in investment intensity.
Intangibles to Assets
What it measures: The proportion of total assets that consists of intangible assets, including patents, trademarks, acquired technology, customer relationships, brand value, and other non-physical assets (excluding goodwill, which is measured separately). When intangibles represent a large share of total assets, the company's balance sheet is structurally dependent on non-physical property. This signal captures the degree to which the company's reported asset base consists of items whose value depends on ongoing competitive relevance, legal protection, and market demand rather than physical substance. High intangible-to-asset ratios indicate a company whose economic reality is poorly captured by tangible book value alone.
Data source: Intangible assets (excluding goodwill) from the balance sheet divided by total assets, providing a measure of non-physical asset concentration.
Goodwill to Assets
What it measures: Goodwill as a proportion of total assets. Goodwill arises specifically from acquisitions — it represents the premium paid above the fair value of acquired net assets. When goodwill dominates the asset base, the company's balance sheet is substantially shaped by past acquisition decisions and the prices paid for them. Unlike other intangible assets, goodwill is not amortized under current accounting standards but is subject to impairment testing. A company with goodwill representing 40% of total assets has significant exposure to impairment charges if the acquired businesses underperform their purchase expectations. This signal distinguishes acquisition-driven intangible accumulation from organically developed intellectual property.
Data source: Goodwill from the balance sheet divided by total assets, isolating the acquisition premium component of the intangible asset base.
Stories That Emerge
R&D Investment Profile
Constituent signals: R&D to Revenue, R&D Growth Rate, R&D to Operating Expenses
What emerges: When R&D spending is significant relative to revenue, growing over time, and represents a large share of total operating expenses, the company has a pronounced R&D investment profile. The three signals confirm the structural centrality of research spending from different angles. R&D-to-revenue measures the intensity of the investment relative to the business. R&D growth rate confirms that the commitment is increasing rather than static or declining — a company that is accelerating R&D spending is deepening its innovation bet. And R&D-to-operating-expenses reveals how much of the company's total cost structure is dedicated to research versus other operating activities like sales, marketing, and administration. When all three are elevated, R&D is not a peripheral activity — it is the company's primary operating investment and the dominant driver of its cost structure.
Limits: R&D spending intensity says nothing about R&D productivity. A company spending 30% of revenue on research may be producing breakthrough products with high commercial potential, or it may be burning cash on projects that never reach market. The story measures the structural investment commitment without assessing whether that investment generates returns. Some of the most prolific R&D spenders in history have produced mediocre shareholder returns, while some of the most successful companies spend modestly on research but deploy it with extraordinary precision. Input does not equal output, and this story measures only the input side.
Intangible Asset Concentration
Constituent signals: Intangibles to Assets, Goodwill to Assets, Intangible Asset Intensity
What emerges: When intangible assets dominate the balance sheet, goodwill represents a significant share of total assets, and intangible asset intensity is high, the company's reported value is concentrated in non-physical assets. The convergence of these signals describes a company whose balance sheet is fundamentally different from a tangible-asset-heavy business. The economic value resides in intellectual property, brands, customer relationships, and acquisition premiums rather than in factories, equipment, or inventory. This structural characteristic has implications across multiple dimensions: asset valuation depends on subjective estimates, impairment risk is concentrated in non-physical items, and tangible book value — a common safety-of-principal metric — is a poor representation of the company's actual economic substance.
Limits: Intangible asset concentration is a structural description, not a risk assessment. Companies with intangible-dominated balance sheets include some of the most valuable and competitively advantaged businesses in the world — firms whose brands, patents, and technology platforms are worth far more than any physical asset. The story identifies the structural concentration without assessing whether the intangible assets are durable, well-protected, or likely to maintain their value. Equally, high goodwill concentration may reflect a history of disciplined acquisitions that created genuine value or a history of overpaying for businesses that underperformed. The signal measures the structural outcome on the balance sheet, not the quality of the decisions that produced it.
Innovation-Intensive Model (Combined Pattern)
Constituent signals: R&D to Revenue, Intangibles to Assets, R&D Growth Rate
What emerges: When high R&D spending intensity coincides with a large intangible asset base and accelerating research investment, the company operates an innovation-intensive business model. This combined pattern identifies companies where innovation is both the primary current expenditure (high R&D-to-revenue) and the primary accumulated asset (high intangibles-to-assets), with the trajectory showing deepening commitment (R&D growth rate). These companies are structurally distinct from the broader market — their income statements are depressed by R&D expensing, their balance sheets are dominated by non-physical assets, and their competitive positioning depends on continuous innovation output rather than physical scale or distribution advantages.
Limits: The combined pattern identifies the most innovation-dependent companies, which also tend to be the most difficult to value using standard metrics. Price-to-earnings ratios are inflated by R&D expensing, price-to-book ratios are distorted by intangible asset accounting, and free cash flow may understate economic value creation if R&D spending is building assets that the balance sheet does not recognize. The story identifies the structural model without resolving the valuation challenges that model creates. Innovation-intensive companies require frameworks that account for R&D as investment rather than expense, and standard screener metrics may not provide that adjustment.
Using the Screener
Innovation Investment Screen
Select both R&D Investment Profile and Intangible Asset Concentration to identify companies where heavy current R&D spending coincides with intangible-heavy balance sheets. This combination captures the full innovation investment picture — both the ongoing expenditure and its accumulated balance sheet footprint. Companies passing both stories are structurally committed to innovation as their primary value creation mechanism, with balance sheets that reflect the non-physical nature of their accumulated investments.
This screen is particularly useful for identifying potential holdings in knowledge-economy sectors where standard profitability screens systematically penalize R&D-intensive companies. A company spending heavily on research appears less profitable than peers that spend less — but the spending may be creating future revenue streams and competitive advantages that current-period profitability metrics do not capture. The innovation investment screen finds these companies before the R&D spending produces the revenue growth that conventional screens would eventually detect.
R&D Intensity with Margin Support
Select R&D Investment Profile combined with Margin Stack to find companies that maintain heavy R&D spending while also demonstrating healthy margins across the income statement. This combination identifies a structurally attractive configuration: the company is investing aggressively in innovation but the underlying business generates enough margin to fund that investment without financial strain. High R&D intensity with strong margins suggests either powerful pricing power (the business generates sufficient gross margin to absorb heavy research spending), or exceptional operational efficiency (the company manages non-R&D costs tightly enough to preserve profitability despite large research budgets).
The margin stack overlay filters out R&D-intensive companies that are burning cash to fund research — a pattern that may or may not produce returns — and isolates those where the current business economics support the innovation investment. This distinction matters because sustainable R&D programs are typically funded by operating cash flow from the existing business, while unsustainable ones depend on external capital that may not always be available.
Boundaries
What This Cannot Tell You
Innovation investment signals measure spending intensity and balance sheet composition. They do not measure innovation output, effectiveness, or commercial potential. A company with the highest R&D-to-revenue ratio in its industry may be producing groundbreaking products or wasting capital on projects with no market application. The relationship between R&D spending and commercial success is notoriously difficult to quantify — some of the most impactful innovations in business history emerged from modest research budgets, while some of the largest R&D programs have produced disappointing results. These signals identify the structural commitment to innovation without assessing whether that commitment is producing value.
Intangible asset signals carry additional limitations related to accounting treatment. Internally developed intangible assets — the products of a company's own R&D — are generally not recognized on the balance sheet under most accounting frameworks. This means that companies with the most valuable organically developed technology may show lower intangible-to-asset ratios than companies that acquired their technology through acquisitions (which does create balance sheet intangibles). The intangible asset concentration story captures what accounting rules allow onto the balance sheet, which is a biased sample of the company's actual intangible value. Companies that grow through internal development and companies that grow through acquisition will show very different intangible profiles even if their actual intellectual property portfolios are similar in value.
Finally, R&D and intangible asset analysis is most meaningful within industry context. R&D-to-revenue ratios, intangible asset concentrations, and goodwill levels vary enormously across sectors. A 15% R&D-to-revenue ratio is unremarkable in biotechnology but extraordinary in consumer staples. A goodwill-to-assets ratio of 50% is common in companies that grow through acquisitions but absent in companies that grow organically. These signals are most informative when used to compare companies within similar industries or to track changes over time for a specific company, rather than as absolute thresholds applied across the entire market.